Mark I. Greene

6.6k citations

74 papers · 5.3k indexed · 1 hit paper · h-index 27

Impact in

Oncology top 0.5%
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
Radiology, Nuclear Medicine and Imaging top 0.5%
- Monoclonal and Polyclonal Antibodies Research

Papers in

Radiology, Nuclear Medicine and Imaging 44
- Monoclonal and Polyclonal Antibodies Research 43
Oncology 32
- HER2/EGFR in Cancer Research 23
- CAR-T cell therapy research 6

Co-authors: Jeffrey A. Drebin David F. Stern Robert A. Weinberg A.H. Sehon Shigeyoshi Fujimoto Ramachandran Murali Alan Berezov Stuart J. Decker
Journals: Nature Biotechnology (4 papers)Pathobiology (4 papers)The Journal of Immunology (3 papers)Proceedings of the National Academy of Sciences (3 papers)Immunologic Research (3 papers)
Partner nations: United States Japan Canada

In The Last Decade

Mark I. Greene

74 papers receiving 5.0k citations

Hit Papers

align trajectories log scale

The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen 1984 · 938 citations

Peers

Countries citing papers authored by Mark I. Greene

Since Specialization

Citations

This map shows the geographic impact of Mark I. Greene's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark I. Greene with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark I. Greene more than expected).

Fields of papers citing papers by Mark I. Greene

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark I. Greene. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark I. Greene. The network helps show where Mark I. Greene may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark I. Greene, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark I. Greene Line = papers co-authored together Mark I. Greene links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	F77 antigen is a promising target for adoptive T cell therapy of prostate cancer Biochemical and Biophysical Research Communications ·Payal Grover, Selene Nuñez-Cruz, John Leferovich, Tyra Wentz, Atrish Bagchi, Michael C. Milone, Mark I. Greene	2023	6
2	Development of anti-EGF receptor peptidomimetics (AERP) as tumor imaging agent Bioorganic & Medicinal Chemistry Letters ·Datta E. Ponde, Zi-Fen Su, Alan Berezov, Hongtao Zhang, Abbas Alavi, Mark I. Greene, Ramachandran Murali	2011	6
3	The Therapeutic Effect of Anti-HER2/neu Antibody Depends on Both Innate and Adaptive Immunity Cancer Cell ·SaeGwang Park, Zhujun Jiang, Eric D. Mortenson, Liufu Deng, Olga Radkevich-Brown, Xuanming Yang, Husain Sattar, Yang Wang, Nicholas K. Brown, Mark I. Greene, Yang Liu, Jie Tang, Shengdian Wang, Yang‐Xin Fu	2010	433
4	Non-invasive, ultra-sensitive, high-throughput assays to quantify rare biomarkers in the blood Methods ·Jaclyn A. Freudenberg, Kathryn Bembas, Mark I. Greene, Hongtao Zhang	2008	13
5	Targeted Antireceptor Therapy with Monoclonal Antibodies Leads to the Formation of Inactivated Tetrameric Forms of ErbB Receptors The Journal of Immunology ·Keiji Furuuchi, Alan Berezov, Toru Kumagai, Mark I. Greene	2007	20
6	ErbB receptors: from oncogenes to targeted cancer therapies Journal of Clinical Investigation ·Hongtao Zhang, Alan Berezov, Qiang Wang, Geng Zhang, Jeffrey A. Drebin, Ramachandran Murali, Mark I. Greene	2007	454
7	The Gefitinib-Sensitizing Mutant Epidermal Growth Factor Receptor Enables Transformation of a Mouse Fibroblast Cell Line DNA and Cell Biology ·Izumi Nagatomo, Toru Kumagai, Tadahiro Yamadori, Mitsugi Furukawa, Ryo Takahashi, Tsutomu Yoneda, Yoshitaka Ogata, Yoshiyuki Saito, Koji Inoue, Yukihiro Yano, Takashi Kijima, Mitsuhiro Yoshida, Tadashi Osaki, Isao Tachibana, Mark I. Greene, Ichiro Kawase	2006	10
8	Therapeutic Monoclonal Antibodies for the ErbB Family of Receptor Tyrosine Kinases Cancer Biology & Therapy ·Hongtao Zhang, Mark Richter, Mark I. Greene	2003	9
9	HER2/Neu: mechanisms of dimerization/oligomerization Oncogene ·Patrick J. Brennan, Toru Kumogai, Alan Berezov, Ramachandran Murali, Mark I. Greene	2000	138
10	Rationally designed anti-HER2/neu peptide mimetic disables P185HER2/neu tyrosine kinases in vitro and in vivo Nature Biotechnology ·Byeong‐Woo Park, Hongtao Zhang, Chuan-Jin Wu, Alan Berezov, Xin Zhang, Raj Dua, Qiang Wang, Gary D. Kao, Donald M. O’Rourke, Mark I. Greene, Ramachandran Murali	2000	155
11	Induction of the Tat-binding protein 1 gene accompanies the disabling of oncogenic erbB receptor tyrosine kinases Proceedings of the National Academy of Sciences ·Byeong‐Woo Park, Donald M. O’Rourke, Qiang Wang, James G. Davis, Andrew Post, Xiaolan Qian, Mark I. Greene	1999	16
12	Synthetic CD4 exocyclics inhibit binding of human immunodeficiency virus type 1 envelope to CD4 and virus replication in T lymphocytes Nature Biotechnology ·Xin Zhang, Muriel Gaubin, Laurence Briant, Vasantha Srikantan, Ramachandran Murali, H. Uri Saragovi, David B. Weiner, Christian Devaux, Monica Autiero, Dominique Piatier‐Tonneau, Mark I. Greene	1997	35
13	Relationship of p215BRCA1 to tyrosine kinase signaling pathways and the cell cycle in normal and transformed cells Oncogene ·Hongtao Zhang, Xin Zhang, Huizhen Zhao, Yuri Kajino, Barbara L. Weber, James G. Davis, Qiang Wang, Donald M. O’Rourke, Hongbing Zhang, Kiichi Kajino, Mark I. Greene	1997	20
14	Frequent deletion of the transgene in T cell receptor β chain transgenic mice International Immunology ·Shinji Komori, Makoto Katsumata, Mark I. Greene, Katsuyuki Yui	1993	2
15	CD4−CD8+ T-cell receptor-αβ+ major histocompatibility complex class-II-specific T-cell clones isolated from aged athymic micemajor histocompatibility complex class-II-specific T-cell clones isolated from aged athymic mice Immunologic Research ·Katsuyuki Yui, Mark I. Greene	1992	1
16	Biological effects of monoclonal antireceptor antibodies reactive with neu oncogene product, p185neu Methods in enzymology on CD-ROM/Methods in enzymology ·Jeffrey N. Myers, Jeffrey A. Drebin, Takuro Wada, Mark I. Greene	1991	6
17	Expression of c-erbB-2 in Human Pancreatic Adenocarcinomas Pathobiology ·Thomas Williams, David B. Weiner, Mark I. Greene, Henry Maguire	1991	54
18	p185neu expression in human lung adenocarcinomas predicts shortened survival. PubMed ·Jeffrey A. Kern, David A. Schwartz, Joanne E. Nordberg, David B. Weiner, Mark I. Greene, Lisa Torney, Robert A. Robinson	1990	373
19	Inhibition of T cell developmemt in thymic organ culture: Implications for the mechanism of action of cyclosporin A European Journal of Immunology ·Richard M. Siegel, Katsuyuki Yui, Drew E. Tenenholz, Ralph T. Kubo, Mark I. Greene	1990	11
20	Differential Regulation of Oncogenic and Cellular p185 by Serine/Threonine Kinases DNA ·Kunio Dobashi, David B. Weiner, Mark I. Greene	1989	17

About Mark I. Greene

Mark I. Greene is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Immunology, Space and Planetary Science and Molecular Biology, having authored 74 papers that have together received 5.3k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (43 papers), HER2/EGFR in Cancer Research (23 papers), Glycosylation and Glycoproteins Research (17 papers), Immune Cell Function and Interaction (11 papers), T-cell and B-cell Immunology (10 papers), Virus-based gene therapy research (6 papers), CAR-T cell therapy research (6 papers) and Chemical Synthesis and Analysis (5 papers). The work is most often cited by research in Oncology (2.8k citations), Radiology, Nuclear Medicine and Imaging (2.0k citations), Immunology (1.3k citations), Immunology and Allergy (227 citations) and Molecular Biology (2.3k citations). Mark I. Greene has collaborated with scholars based in United States, Japan and Canada. Frequent co-authors include Jeffrey A. Drebin, David F. Stern, Robert A. Weinberg, A.H. Sehon, Shigeyoshi Fujimoto, Ramachandran Murali, Alan Berezov, Stuart J. Decker, Alan L. Schechter and Hongtao Zhang. Their work appears in journals such as Nature Biotechnology, Pathobiology, The Journal of Immunology, Proceedings of the National Academy of Sciences and Immunologic Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact